(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.05%) $79.04
(0.21%) $1.936
(0.87%) $2 331.00
(0.83%) $26.97
(1.02%) $964.60
(0.00%) $0.933
(-0.11%) $11.02
(-0.07%) $0.798
(0.06%) $93.51
Live Chart Being Loaded With Signals
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases...
Stats | |
---|---|
Dagens volum | 23.92M |
Gjennomsnittsvolum | 0.00 |
Markedsverdi | 26.63B |
EPS | $1.250 ( 2023-11-01 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 61.86 |
ATR14 | $0.803 (0.69%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-06 | Watkins Thomas | Sell | 10 000 | Ordinary Shares |
2023-10-06 | Watkins Thomas | Sell | 8 548 | Stock Option (Right to Buy) |
2023-10-06 | Watkins Thomas | Sell | 23 092 | Stock Option (Right to Buy) |
2023-10-06 | Watkins Thomas | Sell | 31 153 | Stock Option (Right to Buy) |
2023-10-06 | Watkins Thomas | Sell | 10 838 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-89.06 |
Last 100 transactions |
Buy: 244 079 | Sell: 3 988 089 |
Volum Korrelasjon
Horizon Therapeutics PLC Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
BOCH | 0.96 |
NWFL | 0.955 |
WLFC | 0.945 |
PPH | 0.944 |
SNY | 0.943 |
DVCR | 0.941 |
SHSP | 0.94 |
ROST | 0.938 |
MGI | 0.937 |
EWEB | 0.937 |
10 Mest negative korrelasjoner | |
---|---|
GAINL | -0.964 |
QTEK | -0.96 |
FATE | -0.959 |
LNSR | -0.957 |
IMCC | -0.953 |
VS | -0.95 |
QLGN | -0.949 |
WISA | -0.947 |
TOPS | -0.945 |
LHDX | -0.945 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Horizon Therapeutics PLC Korrelasjon - Valuta/Råvare
Horizon Therapeutics PLC Økonomi
Annual | 2022 |
Omsetning: | $3.63B |
Bruttogevinst: | $2.71B (74.64 %) |
EPS: | $2.28 |
FY | 2022 |
Omsetning: | $3.63B |
Bruttogevinst: | $2.71B (74.64 %) |
EPS: | $2.28 |
FY | 2021 |
Omsetning: | $3.23B |
Bruttogevinst: | $2.43B (75.37 %) |
EPS: | $2.37 |
FY | 2020 |
Omsetning: | $2.20B |
Bruttogevinst: | $1.67B (75.79 %) |
EPS: | $1.910 |
Financial Reports:
No articles found.
Horizon Therapeutics PLC
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.